Literature DB >> 16763967

Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging.

A A Maudsley1, A Darkazanli, J R Alger, L O Hall, N Schuff, C Studholme, Y Yu, A Ebel, A Frew, D Goldgof, Y Gu, R Pagare, F Rousseau, K Sivasankaran, B J Soher, P Weber, K Young, X Zhu.   

Abstract

Image reconstruction for magnetic resonance spectroscopic imaging (MRSI) requires specialized spatial and spectral data processing methods and benefits from the use of several sources of prior information that are not commonly available, including MRI-derived tissue segmentation, morphological analysis and spectral characteristics of the observed metabolites. In addition, incorporating information obtained from MRI data can enhance the display of low-resolution metabolite images and multiparametric and regional statistical analysis methods can improve detection of altered metabolite distributions. As a result, full MRSI processing and analysis can involve multiple processing steps and several different data types. In this paper, a processing environment is described that integrates and automates these data processing and analysis functions for imaging of proton metabolite distributions in the normal human brain. The capabilities include normalization of metabolite signal intensities and transformation into a common spatial reference frame, thereby allowing the formation of a database of MR-measured human metabolite values as a function of acquisition, spatial and subject parameters. This development is carried out under the MIDAS project (Metabolite Imaging and Data Analysis System), which provides an integrated set of MRI and MRSI processing functions. It is anticipated that further development and distribution of these capabilities will facilitate more widespread use of MRSI for diagnostic imaging, encourage the development of standardized MRSI acquisition, processing and analysis methods and enable improved mapping of metabolite distributions in the human brain. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763967      PMCID: PMC2673915          DOI: 10.1002/nbm.1025

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  26 in total

1.  Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis.

Authors:  A Ebel; B J Soher; A A Maudsley
Journal:  Magn Reson Med       Date:  2001-12       Impact factor: 4.668

2.  Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy.

Authors:  Andreas Ebel; Andrew A Maudsley
Journal:  Magn Reson Imaging       Date:  2003-02       Impact factor: 2.546

3.  Novel methodology for the archiving and interactive reading of clinical magnetic resonance spectroscopic imaging.

Authors:  Jeffry R Alger; Andrew J Frew; Timothy F Cloughesy; Walter Del Vecchio; J Pablo Villablanca; John G Curran
Journal:  Magn Reson Med       Date:  2002-09       Impact factor: 4.668

4.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.

Authors:  N Schuff; F Ezekiel; A C Gamst; D L Amend; A A Capizzano; A A Maudsley; M W Weiner
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

5.  Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.

Authors:  E Angelie; A Bonmartin; A Boudraa; P M Gonnaud; J J Mallet; D Sappey-Marinier
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

6.  Estimating tissue deformation between functional images induced by intracranial electrode implantation using anatomical MRI.

Authors:  C Studholme; E Novotny; I G Zubal; J S Duncan
Journal:  Neuroimage       Date:  2001-04       Impact factor: 6.556

7.  Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem.

Authors:  M A Jacobs; A Horská; P C van Zijl; P B Barker
Journal:  Magn Reson Med       Date:  2001-10       Impact factor: 4.668

8.  Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility.

Authors:  Jeroen J G Geurts; Frederik Barkhof; Jonas A Castelijns; Bernard M J Uitdehaag; Chris H Polman; Petra J W Pouwels
Journal:  J Magn Reson Imaging       Date:  2004-09       Impact factor: 4.813

9.  Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.

Authors:  N Schuff; A A Capizzano; A T Du; D L Amend; J O'Neill; D Norman; W J Jagust; H C Chui; J H Kramer; B R Reed; B L Miller; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

10.  Spectroscopic imaging display and analysis.

Authors:  A A Maudsley; E Lin; M W Weiner
Journal:  Magn Reson Imaging       Date:  1992       Impact factor: 2.546

View more
  90 in total

Review 1.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 2.  Whole Brain ¹H-Spectroscopy: A Developing Technique for Advanced Analysis of Cerebral Metabolism.

Authors:  X-Q Ding; H Lanfermann
Journal:  Clin Neuroradiol       Date:  2015-07-09       Impact factor: 3.649

Review 3.  Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.

Authors:  Ovidiu C Andronesi; Otto Rapalino; Elizabeth Gerstner; Andrew Chi; Tracy T Batchelor; Dan P Cahill; A Gregory Sorensen; Bruce R Rosen
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

4.  FID modulus: a simple and efficient technique to phase and align MR spectra.

Authors:  Yann Le Fur; Patrick J Cozzone
Journal:  MAGMA       Date:  2013-06-21       Impact factor: 2.310

5.  Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS.

Authors:  Charlotte J Stagg; Steven Knight; Kevin Talbot; Mark Jenkinson; Andrew A Maudsley; Martin R Turner
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

6.  Whole-brain proton MR spectroscopic imaging in Parkinson's disease.

Authors:  Bonnie E Levin; Heather L Katzen; Andrew Maudsley; Judith Post; Connie Myerson; Varan Govind; Fatta Nahab; Blake Scanlon; Aaron Mittel
Journal:  J Neuroimaging       Date:  2012-12-10       Impact factor: 2.486

7.  Reproducibility of serial whole-brain MR spectroscopic imaging.

Authors:  A A Maudsley; C Domenig; S Sheriff
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

8.  Multivariate statistical mapping of spectroscopic imaging data.

Authors:  Karl Young; Varan Govind; Khema Sharma; Colin Studholme; Andrew A Maudsley; Norbert Schuff
Journal:  Magn Reson Med       Date:  2010-01       Impact factor: 4.668

9.  Fast 3D rosette spectroscopic imaging of neocortical abnormalities at 3 T: Assessment of spectral quality.

Authors:  Claudiu V Schirda; Tiejun Zhao; Victor E Yushmanov; Yoojin Lee; Gena R Ghearing; Frank S Lieberman; Ashok Panigrahy; Hoby P Hetherington; Jullie W Pan
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

10.  Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS.

Authors:  Colin Quinn; Lauren Elman; Leo McCluskey; Katelin Hoskins; Chafic Karam; John H Woo; Harish Poptani; Sumei Wang; Sanjeev Chawla; Scott E Kasner; Murray Grossman
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.